Chie Kikutake1, Mikita Suyama1. 1. Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Abstract
BACKGROUND: Open chromatin is associated with gene transcription. Previous studies have shown that the density of mutations in open chromatin regions is lower than that in flanking regions because of the higher accessibility of DNA repair machinery. However, in several cancer types, open chromatin regions show an increased local density of mutations in activated regulatory regions. Although the mutation distribution within open chromatin regions in cancer cells has been investigated, only few studies have focused on their functional implications in cancer. To reveal the impact of highly mutated open chromatin regions on cancer, we investigated the association between mutations in open chromatin regions and their possible functions. METHODS: Whole-genome sequencing data of 18 cancer types were downloaded from the PanCancer Analysis of Whole Genomes and Catalog of Somatic Mutations in Cancer. We quantified the mutations located in open chromatin regions defined by The Cancer Genome Atlas and classified open chromatin regions into three categories based on the number of mutations. Then, we investigated the chromatin state, amplification, and possible target genes of the open chromatin regions with a high number of mutations. We also analyzed the association between the number of mutations in open chromatin regions and patient prognosis. RESULTS: In some cancer types, the proportion of promoter or enhancer chromatin state in open chromatin regions with a high number of mutations was significantly higher than that in the regions with a low number of mutations. The possible target genes of open chromatin regions with a high number of mutations were more strongly associated with cancer than those of other open chromatin regions. Moreover, a high number of mutations in open chromatin regions was significantly associated with a poor prognosis in some cancer types. CONCLUSIONS: These results suggest that highly mutated open chromatin regions play an important role in cancer pathogenesis and can be effectively used to predict patient prognosis.
BACKGROUND: Open chromatin is associated with gene transcription. Previous studies have shown that the density of mutations in open chromatin regions is lower than that in flanking regions because of the higher accessibility of DNA repair machinery. However, in several cancer types, open chromatin regions show an increased local density of mutations in activated regulatory regions. Although the mutation distribution within open chromatin regions in cancer cells has been investigated, only few studies have focused on their functional implications in cancer. To reveal the impact of highly mutated open chromatin regions on cancer, we investigated the association between mutations in open chromatin regions and their possible functions. METHODS: Whole-genome sequencing data of 18 cancer types were downloaded from the PanCancer Analysis of Whole Genomes and Catalog of Somatic Mutations in Cancer. We quantified the mutations located in open chromatin regions defined by The Cancer Genome Atlas and classified open chromatin regions into three categories based on the number of mutations. Then, we investigated the chromatin state, amplification, and possible target genes of the open chromatin regions with a high number of mutations. We also analyzed the association between the number of mutations in open chromatin regions and patient prognosis. RESULTS: In some cancer types, the proportion of promoter or enhancer chromatin state in open chromatin regions with a high number of mutations was significantly higher than that in the regions with a low number of mutations. The possible target genes of open chromatin regions with a high number of mutations were more strongly associated with cancer than those of other open chromatin regions. Moreover, a high number of mutations in open chromatin regions was significantly associated with a poor prognosis in some cancer types. CONCLUSIONS: These results suggest that highly mutated open chromatin regions play an important role in cancer pathogenesis and can be effectively used to predict patient prognosis.
Authors: Matthew J Ellis; Michael Gillette; Steven A Carr; Amanda G Paulovich; Richard D Smith; Karin K Rodland; R Reid Townsend; Christopher Kinsinger; Mehdi Mesri; Henry Rodriguez; Daniel C Liebler Journal: Cancer Discov Date: 2013-10 Impact factor: 39.397
Authors: Bradley E Bernstein; John A Stamatoyannopoulos; Joseph F Costello; Bing Ren; Aleksandar Milosavljevic; Alexander Meissner; Manolis Kellis; Marco A Marra; Arthur L Beaudet; Joseph R Ecker; Peggy J Farnham; Martin Hirst; Eric S Lander; Tarjei S Mikkelsen; James A Thomson Journal: Nat Biotechnol Date: 2010-10 Impact factor: 54.908
Authors: Helen Zhu; Liis Uusküla-Reimand; Keren Isaev; Lina Wadi; Azad Alizada; Shimin Shuai; Vincent Huang; Dike Aduluso-Nwaobasi; Marta Paczkowska; Diala Abd-Rabbo; Oliver Ocsenas; Minggao Liang; J Drew Thompson; Yao Li; Luyao Ruan; Michal Krassowski; Irakli Dzneladze; Jared T Simpson; Mathieu Lupien; Lincoln D Stein; Paul C Boutros; Michael D Wilson; Jüri Reimand Journal: Mol Cell Date: 2020-01-17 Impact factor: 17.970
Authors: Hoon Kim; Nam-Phuong Nguyen; Kristen Turner; Sihan Wu; Amit D Gujar; Jens Luebeck; Jihe Liu; Viraj Deshpande; Utkrisht Rajkumar; Sandeep Namburi; Samirkumar B Amin; Eunhee Yi; Francesca Menghi; Johannes H Schulte; Anton G Henssen; Howard Y Chang; Christine R Beck; Paul S Mischel; Vineet Bafna; Roel G W Verhaak Journal: Nat Genet Date: 2020-08-17 Impact factor: 41.307